I now have excellent comprehensive data from multiple authoritative sources. Let me compile the full detailed answer.
Headache: Definition, Types, and Treatment
Headache Classification - Frameworks for Internal Medicine
What is a Headache?
A headache is pain or discomfort felt anywhere in the head, scalp, neck, or upper back that arises from pain-sensitive structures - including blood vessels, meninges, cranial nerves, and muscles. The brain tissue itself has no pain receptors; headache pain arises when surrounding structures are irritated, inflamed, stretched, or compressed.
Headache is one of the most common medical complaints worldwide, affecting approximately 90% of individuals during their lifetime (J Am Board Fam Med, 2024). It is consistently among the top reasons for emergency department visits.
Classification: Primary vs. Secondary
Headaches are divided into two fundamental categories:
| Category | Definition | Examples |
|---|
| Primary | The headache itself is the disorder; no underlying disease causes it | Tension-type, Migraine, Cluster |
| Secondary | Headache is a symptom of another condition | Meningitis, brain tumor, SAH, hypertension |
Headaches occurring fewer than 15 days/month are episodic; those occurring more than 15 days/month are chronic.
PRIMARY HEADACHES
1. Tension-Type Headache (TTH)
The most common type of headache.
Features:
- Location: Bilateral, described as a "band" or "vice" around the entire head
- Character: Dull, persistent, pressing/tightening - NOT throbbing
- Severity: Mild to moderate
- Duration: 30 minutes to 7 days
- NOT worsened by physical activity (unlike migraine)
- May have mild light/sound sensitivity and mild anorexia, but no nausea/vomiting
Subtypes:
- Infrequent episodic - less than 1 day/month
- Frequent episodic - 1-14 days/month
- Chronic - more than 15 days/month
Triggers: Stress, reduced sleep, missed meals, muscle tension in neck/shoulders
Treatment:
- Acute: Ibuprofen 400 mg or acetaminophen 1000 mg (NSAIDs preferred); aspirin
- Prevention (chronic TTH): Amitriptyline 50-100 mg significantly reduces monthly headache days
- Non-pharmacological: Cognitive behavioral therapy, adequate rest, moist heat, massage, aerobic exercise
2. Migraine
The second most common primary headache, and the most disabling.
Features:
- Location: Usually unilateral (one side), but can be bilateral
- Character: Pulsating, throbbing
- Severity: Moderate to severe
- Duration: 2-72 hours per episode
- Worsened by physical activity
- Associated symptoms: Nausea, vomiting, photophobia (light sensitivity), phonophobia (sound sensitivity), osmophobia (smell sensitivity)
- Frequency: 1-5 attacks per month in severe cases
Migraine Phases:
- Prodrome (hours to days before): fatigue, difficulty concentrating, mood changes
- Aura (in ~30% of patients): visual disturbances (zigzag lines, blind spots), sensory symptoms, or speech difficulty - usually lasts 20-60 minutes
- Headache phase: the main throbbing pain
- Postdrome: fatigue, confusion after pain resolves
Pathophysiology: The aura is caused by cortical spreading depression - a wave of neuronal suppression - associated with brief reduction in blood flow followed by hyperemia. Pain occurs when trigeminal afferents of the dura are stimulated. Calcitonin gene-related peptide (CGRP) plays a key role in migraine pain signaling.
Comorbidities: Epilepsy, depression, anxiety, stroke, fibromyalgia, irritable bowel syndrome.
Treatment - Acute (Mild attacks):
- Acetaminophen 650-1000 mg
- NSAIDs: Aspirin 250-1000 mg, Ibuprofen 400-600 mg, Naproxen 500-825 mg, Diclofenac 50 mg
Treatment - Acute (Moderate/Severe attacks):
- Triptans (first-line migraine-specific): Sumatriptan, Rizatriptan, Zolmitriptan, Eletriptan, Frovatriptan, Naratriptan, Almotriptan - these are serotonin (5-HT1B/1D) agonists that cause vasoconstriction and block pain signals. Contraindicated in cardiovascular disease.
- Gepants (CGRP antagonists): Ubrogepant, Rimegepant - for patients who cannot tolerate triptans; oral administration, lower cardiovascular risk
- Ergotamine/Dihydroergotamine (DHE): Older agents, still used for severe/refractory migraines
- Parenteral options (emergency): Dopamine antagonists (metoclopramide, prochlorperazine), ketorolac IV
- Note: Opioids are NOT recommended for primary headaches
Treatment - Prevention (if 2+ attacks/month):
- Beta-blockers (first-line): Propranolol, Metoprolol
- Anticonvulsants: Topiramate, Divalproex sodium (valproate)
- Antidepressants: Amitriptyline, Venlafaxine
- Calcium channel blockers: Verapamil
- CGRP monoclonal antibodies (newer): Erenumab, Galcanezumab, Fremanezumab, Eptinezumab (injectable, once monthly/quarterly)
- Oral CGRP antagonists (prevention): Rimegepant, Atogepant
- OnabotulinumtoxinA (Botox): For chronic migraine (not episodic)
- Aerobic exercise and physiotherapy can also reduce attack frequency
3. Cluster Headache
The most severe primary headache - often called "suicide headache" due to its intensity.
Features:
- Location: Strictly unilateral - behind or around ONE eye; never switches sides during an attack
- Character: Excruciating, sharp, stabbing, steady (not throbbing)
- Severity: Extreme - among the most painful conditions known
- Duration: 15-90 minutes per episode
- Occurs in "clusters" - multiple attacks per day (1-8/day) for weeks to months, followed by remission periods
- Onset: Often during sleep
- Sex: Males more often than females (3:1)
- Autonomic features (hallmark): Ipsilateral lacrimation, nasal congestion/rhinorrhea, ptosis (drooping eyelid), miosis, facial flushing, sweating around the eye
- Patient is typically restless and agitated (unlike migraine patients who prefer to lie still)
Treatment - Acute (abortive):
- 100% oxygen inhalation (7-12 L/min for 15 minutes) - highly effective, fast onset
- Sumatriptan (subcutaneous injection 6 mg) - fastest-acting triptan for cluster
- Zolmitriptan nasal spray
Treatment - Prevention:
- Verapamil (calcium channel blocker) - first-line preventive
- Lithium - for chronic cluster
- Topiramate, Divalproex
- Short-course corticosteroids - to break a cluster cycle
- Occipital nerve blocks (injections)
4. Other Notable Primary Headaches
| Type | Key Feature |
|---|
| Hemicrania continua | Continuous, strictly one-sided, responds only to indomethacin |
| Chronic daily headache | Headache on >15 days/month for >3 months |
| Medication overuse headache (MOH) | From overusing pain medications (especially opioids, triptans >10-15 days/month); treated by gradual withdrawal |
| Exertional headache | Triggered by physical exertion |
| Ice pick headache | Brief, stabbing jabs of pain |
| Thunderclap headache | Maximum-intensity headache within 1 minute - ALWAYS requires emergency evaluation to rule out subarachnoid hemorrhage (SAH) |
SECONDARY HEADACHES
These are caused by an identifiable underlying condition. The headache resolves when the underlying cause is treated.
Red Flags ("SNOOP4" features that demand urgent workup):
- Systemic symptoms (fever, weight loss) or immunosuppression (HIV, cancer)
- Neurological deficits (focal weakness, vision loss, confusion)
- Onset sudden/thunderclap ("worst headache of my life")
- Older age at onset (new headache after age 50)
- Progressive worsening
- Posture-related (worse lying down, or only when upright)
- Papilledema (raised intracranial pressure)
- Pregnancy
Common Secondary Headache Causes:
| Cause | Key Features |
|---|
| Subarachnoid hemorrhage (SAH) | Thunderclap headache; "worst headache of life"; emergency - CT head then LP |
| Meningitis/Encephalitis | Fever, neck stiffness, photophobia, altered consciousness |
| Idiopathic intracranial hypertension | Obese women; pulsatile tinnitus, papilledema; treated with acetazolamide, weight loss |
| Intracranial hypotension | Worse when upright, better lying down; caused by CSF leak |
| Brain tumor | Progressive headache, worse in morning, with vomiting, focal deficits |
| Hypertension headache | BP usually >180/120; occipital, morning headache |
| Temporal (giant cell) arteritis | Age >50; tender scalp/temporal artery; risk of blindness; treat with steroids |
| Sinus headache | Facial pressure/tenderness, nasal congestion, worse bending forward |
| Post-traumatic headache | Follows head injury; can persist for months |
Comparison Table: The Three Main Primary Headaches
| Feature | Migraine | Cluster | Tension-Type |
|---|
| Location | Usually unilateral | Behind/around one eye | Bilateral "band" |
| Character | Pulsating, throbbing | Excruciating, sharp, steady | Dull, pressing, tightening |
| Severity | Moderate-severe | Severe-excruciating | Mild-moderate |
| Duration | 2-72 hours | 15-90 minutes | 30 min - 7 days |
| Nausea/Vomiting | Yes | Rarely | No |
| Photophobia/Phonophobia | Yes | Mild | Mild/none |
| Autonomic features | No | Yes (eye tearing, nasal congestion) | No |
| Activity worsens it | Yes | No (patient paces) | No |
| Sex predominance | Female > Male | Male > Female | Female > Male |
| Family history | Yes | No | Sometimes |
| Acute treatment | Triptans, NSAIDs | Oxygen, Sumatriptan SC | NSAIDs, Acetaminophen |
| Prevention | Beta-blockers, CGRP mAbs | Verapamil | Amitriptyline |
General Lifestyle Measures for All Headaches
- Maintain regular sleep schedules
- Stay well-hydrated
- Eat regular meals (avoid skipping)
- Manage stress (mindfulness, CBT, biofeedback)
- Avoid known triggers (alcohol, caffeine excess, bright lights, strong smells)
- Regular aerobic exercise (150 min/week moderate intensity)
- Keep a headache diary to identify patterns and triggers
- Avoid medication overuse (limits >10-15 days/month depending on drug class)
Recent Evidence (2024-2026)
- A 2024 BMJ network meta-analysis found specific triptans and newer gepants had different efficacy and tolerability profiles for acute migraine management, helping refine drug selection.
- A 2026 Lancet Neurology review (PMID: 41722594) highlights significant advances in migraine prevention, particularly with CGRP-targeted therapies.
- The VA 2024 Clinical Practice Guideline recommends ibuprofen 400 mg or acetaminophen 1000 mg for acute tension headache, and amitriptyline for chronic TTH prevention.
Sources: Goldman-Cecil Medicine, 26th Ed. | Lippincott Illustrated Reviews: Pharmacology | Bradley and Daroff's Neurology in Clinical Practice | Rosen's Emergency Medicine | Frameworks for Internal Medicine | ICHD-3 Classification | VA/ACP Headache CPG 2024